Ireland's pharmaceutical industry shipped billions' worth of goods to the U.S., but face threats from Trump 2.0.
The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...
One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...
A groundbreaking study shows how Zepbound, a popular weight loss medication, could become a key treatment for heart failure ...
A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.
A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.
Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...
European Union trade chief Maros Sefcovic said on Thursday that his top priority in trade talks with President Donald Trump's ...
Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...
Companies argue they’re filling a need created by these miracle weight-loss drugs. But are they offering something of real ...